Regulations & Policies

Federal Policy/Regulations regarding Recombinant DNA and Hazardous Agents

NIH Guidelines: The purpose of the NIH Guidelines is to specify practices for constructing and handling: (i) recombinant deoxyribonucleic acid (DNA) molecules, and (ii) organisms and viruses containing recombinant DNA molecules. Clemson University's Institutional Biosafety Committee (IBC) reviews and oversees projects that deal with recombinant DNA technologies, biological and chemical hazards, and select agents.

NIH Guidelines for Research Involving Recombinant DNA molecules

Introduction of genetically engineered organisms into the environment: These Guidelines recommend practices and procedures for the safe conduct of research involving the planned introduction into the environment of certain genetically modified organisms. These Guidelines establish principles for assessing the safety of research with specific organisms and designing confinement to promote safety.

USDA-Guidelines for Research Involving Planned Introduction into the Environment of Genetically Modified Organisms (Dec. 3-4, 1991)

Select Agents: Certain biological organisms and toxins are defined as “Select Agents” by the U.S. Government and have special restrictions on their use; the current list can be accessed below. Anyone desiring to work with these materials must have security clearance to do so and have special security procedures in place for their labs. Investigators wishing to work with any of these agents MUST contact Robin Newberry (the duly authorized responsible official) prior to doing so, and all security clearances and procedures must be in place prior to requesting the Select Agents (note that requests for Select Agents MUST be placed by the Responsible Official). Contact Robin Newberry at (864) 656-1806 for assistance with Select Agent requirements.

Select Agents/Toxins list